Synovex Corp., a drug developer, has raised $3.50 million, or 50 percent of a $7 million share offering, from five investors, according to an SEC filing.
Principals named in the filing by the Cambridge-based company are:
- President Christopher Mirabelli of Cambridge, Mass.-based HealthCare Ventures LLC;
- Director Doug Onsi of HealthCare Ventures LLC;
- Director Rajeev Dadoo of SROne, the venture arm of GlaxoSmithKline with offices in Conshohocken, Pa.;
- Director Ron Laufer of Gaithersburg, Md.-based MedImmune Ventures; and
- Director Isai Peimer of MedImmune Ventures